Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robertson, D. US FDA approves new class of HIV therapeutics. Nat Biotechnol 21, 470–471 (2003). https://doi.org/10.1038/nbt0503-470
Issue Date:
DOI: https://doi.org/10.1038/nbt0503-470
- Springer Nature America, Inc.
This article is cited by
-
Efficient in planta production of amidated antimicrobial peptides that are active against drug-resistant ESKAPE pathogens
Nature Communications (2023)
-
HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes
Nature Chemical Biology (2020)